-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Forte Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
- Forte Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.8M, a 41.9% decline year-over-year.
- Forte Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$37.2M, a 53.5% decline year-over-year.
- Forte Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$32.5M, a 134% decline from 2022.
- Forte Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$13.9M, a 35.3% increase from 2021.
- Forte Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$21.5M, a 53.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)